Advertisement

A Search for Target Cell Structures Associated with Susceptibility to NK Cells

  • Christopher S. Henney
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 146)

Abstract

Natural killer (NK) cells, regardless of the species from which they are derived, are characterized by their ability to lyse a wide variety of cell types, most notably lymphomas and other tumor cell lines. Normal tissues, including fibroblasts, thymocytes and a portion of bone marrow cells are also lysed, but, in general, normal cells are much less susceptible than tumor cells to NK cell mediated lysis (1,2).

Keywords

Natural Killer Natural Killer Cell Fred Hutchinson Cancer Research L5178Y Cell Natural Killer Cell Population 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Henney, C.S., Tracey, D., Durdik, J.M., and G. Klimpel. Am. J. Path. 93:459–468 (1978).PubMedGoogle Scholar
  2. 2.
    Kiessling, R., and H. Wigzell. Immunol. Rev. 44:165–208 (1979)PubMedCrossRefGoogle Scholar
  3. 3.
    Durdik, J.M., Beck, B.N., Clark, E.A., and C.S. Henney. “Natural Cell-Mediated Immunity Against Tumors,” Herberman, R.B., Ed., New York. Academic Press, pp. 805–817 (1980).Google Scholar
  4. 4.
    Brooks, C.G., Kurlbayashi, K., Sale, G.E., and C.S. Henney. J. Immunol., submitted for publication (1981).Google Scholar
  5. 5.
    Durdik, J.M., Beck, B.N., Clark, E.A., and C.S. Henney. J. Immunol. 125:683–688 (1980).PubMedGoogle Scholar
  6. 6.
    Young, W.W., Durdik, J.M., Urdal, D., Hakomori, S., and C.S. Henney. J. Immunol. 126:1–6 (1981).PubMedGoogle Scholar
  7. 7.
    Fishman, P.H., and O. Brady. Science 194:906–915 (1976).PubMedCrossRefGoogle Scholar
  8. 8.
    Hakomori, S., and W.W. Young. Scand. J. Immunol. 6:97–117 (1978).CrossRefGoogle Scholar
  9. 9.
    Sendo, F., Aokl T., Boyse, E.A., and C.K. Buafo. J. Natl. Cancer Inst. 55:603–609 (1975).PubMedGoogle Scholar
  10. 10.
    Nunn, M.E., and R.B. Herberman. J. Natl. Cancer Inst. 62: 765–771 (1979).PubMedGoogle Scholar
  11. 11.
    Dennert, G. Nature 287:47–49 (1980).PubMedCrossRefGoogle Scholar
  12. 12.
    Kiessling, R., Klein, E., and H. Wigzell. Eur. J. Immunol. 5:112–117 (1975).PubMedCrossRefGoogle Scholar
  13. 13.
    Zarling, J.M., Nowinski, R.C., and F.H. Bach. Proc. Natl. Acad. Sci. 72:2780–2784 (1975).PubMedCrossRefGoogle Scholar
  14. 14.
    Becker S., Fenyo, E.M., and E. Klein. Eur. J. Immunol. 6:882–885 (1976).CrossRefGoogle Scholar
  15. 15.
    Roder, J.D., Rosen, A., Fenyo, E.M., and F.A. Troy. Proc. Natl. Acad. Sci. 76:1405–1409 (1979).PubMedCrossRefGoogle Scholar
  16. 16.
    Stutman, O., Dien, P., Wisun, R.E., and E.G. Lattime, Proc. Natl. Acad. Sci. 77:2895–2898 (1980).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Christopher S. Henney
    • 1
  1. 1.Basic Immunology ProgramFred Hutchinson Cancer Research ProgramSeattleUSA

Personalised recommendations